Brief: Valbiotis Confirms Publication Of Results From Study Evaluating Valedia By Mid-2019

Valbiotis SA

06/11/2018 16:54

Nov 6 (Reuters) - VALBIOTIS SAS  ALVAL.PA :
    * CONFIRMS PUBLICATION OF RESULTS FROM INTERNATIONAL PHASE
IIA
CLINICAL STUDY EVALUATING VALEDIA® FOR RISK REDUCTION OF TYPE 2
DIABETES, BY MID-2019
    * RESULTS TO BE PUBLISHED MID-2019
    * LAST SUBJECT INCLUDED IN PHASE IIA CLINICAL STUDY AT
BEGINNING
OF NOVEMBER 2018

Source text for Eikon:  ID:nBw16qS0Ma 
Further company coverage:  ALVAL.PA 

 (Gdynia Newsroom:)
 ((Gdynia.newsroom@thomsonreuters.com; +48 58 772 09 20;))